Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat. Treatment rates by race/ethnicity were 38.8% (White), 31.3% (Black/African American), 31.0% (Hispanic/Latino), and 30.1% (Asian/Pacific Islander/ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lash, Maura K., Latham, Ned H., Chan, Pui Ying, Foote, Mary M.K., Garcia, Elizabeth A., Silverstein, Matthew F., Wong, Marcia, Alexander, Mark, Alroy, Karen A., Bajaj, Lovedeep, Chen, Kuan, Howard, James Steele, Jones, Lucretia E., Lee, Ellen H., Watkins, Julian L., McPherson, Tristan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617352/
https://www.ncbi.nlm.nih.gov/pubmed/37796277
http://dx.doi.org/10.3201/eid2911.230814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617352/
https://www.ncbi.nlm.nih.gov/pubmed/37796277
http://dx.doi.org/10.3201/eid2911.230814

Ejemplares similares